In particular, prolyl 4-hydroxylase, β polypeptide (P4HB), also known as PDIA1, is upregulated in numerous types of cancer [19,20,21,22,23], and its over-expression is associated with advanced-stage tumours and poor prognosis. This evidence concerns the gene P4HB and cancer.